Read + Share
Amedeo Smart
Independent Medical Education
Falkevall A, Mehlem A, Folestad E, Ning FC, et al. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue. J Hepatol 2023;78:901-913.PMID: 36717026
Email
LinkedIn
Facebook
Twitter
Privacy Policy